JCF III AIV I GP Ltd. — Full 13F Portfolio Breakdown
JCF III AIV I GP Ltd.
CIK: 0001673642
Long-term holder
Total reported value
—
Reporting period: 2018-09-30 · Number of holdings: 1
JCF III AIV I GP Ltd. disclosed 1 holdings in its latest 13F filing for the period ending 2018-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Recent moves
Unchanged 000000000
$0.0
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
#
Ticker
Issuer
Asset Subclass
Weight
Weight Change
Shares Change
4Q Trend
1
✓
Ikena Oncology INC
Stock-Other
—
—
—
Portfolio Performance
Not enough priced holdings yet to compute performance
Position changes disclosed by JCF III AIV I GP Ltd. for the quarter ending 2018-09-30, including ticker, issuer, weight change, shares change, and action
What is JCF III AIV I GP Ltd. and what type of investor is it?
JCF III AIV I GP Ltd. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2018-09-30), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are JCF III AIV I GP Ltd.'s largest equity positions?
Based on the latest 13F filing, JCF III AIV I GP Ltd.'s top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did JCF III AIV I GP Ltd. make in its most recent portfolio filing?
No notable portfolio changes were recorded for JCF III AIV I GP Ltd. in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does JCF III AIV I GP Ltd. focus on?
Sector breakdown data is not yet available for JCF III AIV I GP Ltd.. Check back after the next 13F processing cycle.